Physician profile
John E Cade
NPI 1912096157
$6,493.72
in general payments reported to CMS, 2019-2025
40 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,046 · 2020: $367 · 2021: $804 · 2022: $1,331 · 2023: $551 · 2024: $985 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,688 · Long Term Medical Supply Or Device Loan: $245 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.07 |
| Long Term Medical Supply Or Device Loan | $245.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $1,828.33 | 2019-2020 | |
| Treace Medical Concepts, INC. | $1,474.11 | 2021-2024 | |
| Smith+Nephew, INC. | $393.51 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $308.44 | 2022-2025 | Nuzyra |
| Integra Lifesciences Corporation | $245.39 | 2024 | Acell |
| Abbvie INC. | $242.43 | 2021-2022 | |
| Glaxosmithkline, LLC. | $208.45 | 2019-2022 | |
| Alfasigma USA, INC. | $147.12 | 2020-2022 | |
| Nevro Corp. | $136.26 | 2022-2024 | Senza |
| Tactile Systems Technology INC | $131.72 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Heron Therapeutics, INC. | $121.81 | 2022 | |
| In2bones USA, LLC | $120.00 | 2022 | |
| Bioventus LLC | $114.11 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $113.73 | 2019-2021 | |
| Amgen INC. | $81.62 | 2024-2025 | Krystexxa |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $60.91 | 2025 | Purified Cortrophin Gel |
| Abbott Laboratories | $58.45 | 2023 | Proclaim |
| Kerecis Limited | $54.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Misonix INC | $54.53 | 2020-2021 | |
| Horizon Therapeutics Plc | $53.64 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $41.68 | 2022-2025 | Puraply Wound Matrix |
| Orthofix Medical, INC. | $41.36 | 2020-2025 | Physio-Stim |
| Wright Medical Technology, INC. | $39.93 | 2020 | |
| Curonix LLC | $38.80 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Aroa Biosurgery Incorporated | $34.84 | 2025 | |
| Acera Surgical, INC. | $34.28 | 2020-2022 | |
| Forte Bio-Pharma LLC | $31.75 | 2021 | |
| Stimwave Technologies Incorporated | $30.55 | 2021 | |
| Carbofix Orthopedics INC | $26.79 | 2019 | |
| Solventum Corporation | $26.72 | 2025 | Activ.A.C. |
| Ibsa Pharma INC. | $25.00 | 2023 | Tirosint, Licart |
| Zimmer Biomet Holdings, INC. | $23.68 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.47 | 2021 | |
| Medtronic, INC. | $23.41 | 2022 | |
| Koya Medical, INC. | $22.36 | 2025 | Koya Medical, Dayspring |
| Allergan, INC. | $20.59 | 2020 | |
| Grt US Holding, INC. | $20.08 | 2022 | |
| Paragon 28, INC. | $14.41 | 2019 | |
| Medtronic USA, INC. | $12.87 | 2019 | |
| Merck Sharp & Dohme LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.